Another Brick in the Wall: Sintilimab Plus Chemotherapy in Advanced Lung Cancer

J Thorac Oncol. 2020 Oct;15(10):1556-1558. doi: 10.1016/j.jtho.2020.08.013.

Authors

Vincent K Lam¹, Patrick M Forde²

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland.
² Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland. Electronic address: pforde1@jhmi.edu.

PMID: 32981596
DOI: 10.1016/j.jtho.2020.08.013

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Double-Blind Method
Humans
Lung Neoplasms* / drug therapy
Pemetrexed
Platinum*

Substances

Antibodies, Monoclonal, Humanized
Pemetrexed
Platinum
sintilimab